Since in vivo and in vitro models of prion disease, mitochondrial fragmentation, cristae loss, and ATP depletion have been found [15, 28, 39], we wanted to verify the effect of parkin overexpression and of the use of mitophagy activators UA and NMN on mitochondrial morphology and function. This evidence concerns the gene PRKN and prion disease.